Molecular Partners AG (MOLN)
5.34
+0.14
(+2.69%)
USD |
NASDAQ |
Nov 21, 16:00
5.34
0.00 (0.00%)
After-Hours: 19:45
Molecular Partners Price: 5.34 for Nov. 21, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Nov 20, 2024 | 5.42 | 5.455 | 5.19 | 5.200 | 29601.00 |
Nov 19, 2024 | 5.51 | 6.145 | 5.29 | 5.46 | 18160.00 |
Nov 18, 2024 | 5.62 | 5.85 | 5.445 | 5.83 | 10800.00 |
Nov 15, 2024 | 5.33 | 5.42 | 5.11 | 5.33 | 18492.00 |
Nov 14, 2024 | 5.32 | 5.41 | 5.25 | 5.25 | 16866.00 |
Nov 13, 2024 | 5.736 | 5.736 | 5.33 | 5.51 | 34038.00 |
Nov 12, 2024 | 5.67 | 5.743 | 5.44 | 5.690 | 3124.00 |
Nov 11, 2024 | 6.187 | 6.187 | 5.75 | 5.818 | 10692.00 |
Nov 08, 2024 | 6.11 | 6.24 | 5.843 | 6.20 | 8692.00 |
Nov 07, 2024 | 5.93 | 6.24 | 5.87 | 6.03 | 29446.00 |
Nov 06, 2024 | 6.054 | 6.24 | 5.777 | 6.24 | 10508.00 |
Nov 05, 2024 | 5.76 | 6.038 | 5.67 | 5.750 | 9895.00 |
Nov 04, 2024 | 6.13 | 6.185 | 5.82 | 6.056 | 1434.00 |
Nov 01, 2024 | 6.21 | 6.24 | 6.01 | 6.12 | 7813.00 |
Oct 31, 2024 | 6.004 | 6.004 | 5.30 | 5.36 | 21433.00 |
Oct 30, 2024 | 6.17 | 6.25 | 6.08 | 6.15 | 6584.00 |
Oct 29, 2024 | 6.63 | 6.63 | 6.11 | 6.20 | 19525.00 |
Oct 28, 2024 | 6.57 | 6.57 | 6.05 | 6.46 | 38836.00 |
Oct 25, 2024 | 6.53 | 6.90 | 6.40 | 6.49 | 42253.00 |
Oct 24, 2024 | 6.24 | 6.24 | 5.75 | 6.02 | 6746.00 |
Oct 23, 2024 | 6.19 | 6.264 | 5.59 | 5.669 | 17996.00 |
Oct 22, 2024 | 7.30 | 7.60 | 6.23 | 6.57 | 109956.0 |
Oct 21, 2024 | 6.08 | 7.250 | 5.87 | 6.78 | 399676.0 |
Oct 18, 2024 | 5.15 | 5.344 | 4.87 | 4.87 | 17413.00 |
Oct 17, 2024 | 4.91 | 4.99 | 4.91 | 4.98 | 2440.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
3.32
Minimum
Apr 19 2024
31.89
Maximum
Jan 14 2022
9.358
Average
6.439
Median
Price Benchmarks
AC Immune SA | 3.285 |
CRISPR Therapeutics AG | 46.30 |
Addex Therapeutics Ltd | 8.23 |
NLS Pharmaceutics Ltd | 3.39 |
MoonLake Immunotherapeutics | 52.02 |
Price Related Metrics
PS Ratio | 25.94 |
PEG Ratio | -0.3247 |
Price to Book Value | 1.192 |
Earnings Yield | -40.10% |
Market Cap | 196.71M |
PEGY Ratio | -0.3247 |